Related Experiment Video
Updated: Jun 27, 2026
09:31
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Pitfalls in screening programs for congenital hypothyroidism in premature newborns
Amir Kugelman1, Arieh Riskin, David Bader
1Department of Neonatology, Bnai Zion Medical Center, Haifa, Israel. dramir@netvision.net.il
American Journal of Perinatology
|December 17, 2008
Summary
Transient hypothyroxinemia in sick premature infants can mislead early screening. Comprehensive thyroid function evaluation is crucial to avoid missing hypothyroidism in these vulnerable infants.
Area of Science:
- Neonatology
- Endocrinology
- Pediatric Screening
Background:
- Premature infants often exhibit transient hypothyroxinemia due to immature hypothalamic-pituitary-thyroid axis.
- Standard newborn screening may not accurately reflect thyroid status in critically ill premature infants.
Observation:
- A case report highlights the potential for misleading results from standard thyroid screening in sick premature infants.
- Transient hypothyroxinemia can be secondary to hypothalamic-pituitary axis immaturity.
Findings:
- Screening programs should include both thyroid-stimulating hormone (TSH) and thyroxine (T4) levels for premature infants.
- Sick premature infants require comprehensive thyroid function evaluation (free T4 and TSH) beyond initial screening.
Implications:
- Physicians must use clinical judgment to reevaluate for hypothyroidism, even with normal screening tests.
- Recommendations aim to prevent missed diagnoses of primary hypothyroidism in high-risk premature infants.
- Adherence to updated guidelines ensures better management of thyroid dysfunction in neonates.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...